Related content

Gossypol induces apoptosis in multiple myeloma cells by inhibition of interleukin-6 signaling and Bcl-2/Mcl-1 pathway

By  

International Journal of Oncology, Vol. 45, Iss. 6, 2014-01 ,pp. : 2278-2286

Spandidos Publications

Access to resources Recommend Favorite

Phase II Trial of rhIL-6 (Interleukin-6) Prior to and Concurrently with VAD (Vincristine, Doxorubicin and Dexamethasone) Chemotherapy for Patients with Multiple Myeloma

By Young R.I.   Ranson M.   Chang J.   Lord B.   Testa N.   Scarffe J.H.  

European Journal of Cancer, Vol. 33, Iss. 2, 1997-02 ,pp. : 307-311

Elsevier

Access to resources Recommend Favorite

Interleukin-6 in Cervical Cancer: The Relationship with Vascular Endothelial Growth Factor

By Wei L.-H.   Kuo M.-L.   Chen C.-A.   Cheng W.-F.   Cheng S.-P.   Hsieh F.-J.   Hsieh C.-Y.  

Gynecologic Oncology, Vol. 82, Iss. 1, 2001-07 ,pp. : 49-56

Elsevier

Access to resources Recommend Favorite

Tripterygium glycosides inhibit inflammatory mediators in the rat synovial RSC364 cell line stimulated with interleukin1β

By            

Biomedical Reports, Vol. 3, Iss. 6, 2015-01 ,pp. : 763-766

Science Publishers

Access to resources Recommend Favorite

Interleukin6 as a potential molecular target in esophageal squamous cell carcinoma

By            

Oncology Letters, Vol. 11, Iss. 2, 2016-01 ,pp. : 925-932

Spandidos Publications

Access to resources Recommend Favorite